HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Valisure’s Findings Of Benzene In Body Sprays Suggest Ongoing Aerosol Propellant Problem

Executive Summary

Hydrocarbon-based propellants can harbor trace levels of benzene, among other impurities, when quality controls are insufficient. Leading brands’ antiperspirant and deodorant body sprays are the latest aerosol personal-care products identified by independent laboratory Valisure as contaminated with the carcinogen.

You may also be interested in...



CIR On MoCRA Product Listing: FDA Should Refine Categories For Optimal Data Collection

Cosmetic product/ingredient listing required by new cosmetics regulations will be a boon for CIR, which has conducted its ingredient reviews to date based on limited, voluntary data reporting. Adding new product classifications and subcategories to the US FDA’s listing system could provide needed insight into dry shampoo and other product formats and help identify potential for incidental inhalation risks.

Valisure’s Benzene Testing Challenged By PCPC; FDA Focus Should Be Raw Materials, Trade Group Says

On roughly the 1-year anniversary of Valisure’s citizen petition to the FDA regarding benzene detected in body sprays, the Personal Care Products Council weighs in on the matter.

US FDA Seeks Benzene Testing Of 200 Drug Products By Contract Lab

The agency is calling for an ISO 17025-accredited or equivalent partner to screen selected drug products for benzene, following a rash of sunscreen, antiperspirant and other OTC drug product recalls which triggered a rush on testing laboratories, as well as class action filings across the US.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151920

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel